Health Canada — Medical Devices · Canada · 2020-06-05 · Type II
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Reported risk: This notice concerns an issue found with the proton Pencil Beam Scanning (PBS) and Line Scanning (LS) dose calculation algorithms in RayStation 4, 4.5, 4.7, 5, 6, 7, 8A, 8B, 9A and 9B (including all service packs). The effect of the issue is that robustly optimized plans using tangential fields may exhibit hot spots in the vicinity of the patient surface/skin in the delivered dose. These hot spots would not be visible in dose calculated with the RayStation proton pencil beam dose engine. The issue can also be relevant for robustness analysis, and dose tracking of non-robust optimized plans using tangential fields. This issue is relevant for any dose computed with the analytical pencil beam (PB) dose engine, and the non-clinical optimization dose of the Monte Carlo (MC) dose engine. The issue is not relevant for the clinical MC dose engine, which handles the tangential fields correctly.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.